Lv53
840 积分 2026-05-02 加入
Stroke in China: advances in prevention and management on the path to a healthy China
1个月前
已完结
Optimizing Early Antithrombotic Therapy Within 24 Hours of Intravenous Thrombolysis in Acute Ischemic Stroke
2个月前
已完结
Glycoprotein IIb/IIIa Agents in Acute Ischemic Stroke: A Niche in the Making?
2个月前
已完结
Thirty years of intravenous thrombolysis for acute ischemic stroke: Historical perspectives, evidence from randomized trials, and emerging directions
2个月前
已完结
Toward AI-Powered Neurovascular Intervention: From Imaging to XR-Robotic Convergence
2个月前
已完结
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
2个月前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
3个月前
已完结
Thrombolysis for acute ischaemic stroke: current status and future perspectives
3个月前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
3个月前
已完结
Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion
3个月前
已完结
皖公网安备34019202002308
